Europe Relies Too Much on China for Drugs, Fresenius CEO Warns

Europe must quickly shore up its supply of key drug ingredients to prevent their “weaponization” as global trade tensions mount, the chief executive officer of German health-care company Fresenius SE warned.

After years of outsourcing production, Europe has developed an “unhealthy” dependence on China for so-called active pharmaceutical ingredients, Michael Sen said in an interview Monday in Davos.